VPG’s Second Quarter 2026: Orders Jump, Margins Slump, and Humanoid Robots Hover in the Backlog
Ticker: VPG • EPS • earnings surprise • EPS consensus • revenue forecast • book-to-bill
Executive snapshot
The Vishay Precision Group (NYSE: VPG) posted its fiscal 2026 second-quarter results for the quarter ended July 4, 2026. On the surface, orders are disciplined—the company reports net revenues of $83.9 million, up 11.7% year over year. But the margin line is a different song: gross margin came in at 38.6% (vs 40.7% a year ago), and operating margin was a near-echo at 0.4% (compared with 3.6%). Adjusted metrics tell a similar story: adjusted gross margin 38.6% (vs 41.0%), and adjusted operating margin 1.7% (vs 5.4%).
On the bottom line, GAAP diluted net loss per share stood at ($0.13), versus diluted earnings per share of $0.02 in the prior-year quarter. Adjusted diluted net earnings per share were $0.04 versus $0.21 a year earlier. Notably, adjusted EBITDA was $5.5 million with a 6.5% margin.
Bookings surged to $95.5 million, producing a book-to-bill ratio of 1.14, signaling healthy demand that could translate into reprised activity in the back half of fiscal 2026.
Highlights in context
The press release emphasizes momentum in orders, with management citing demand in precision resistors for AI-related semiconductors, data centers, aerospace, and defense. A notable item: the company disclosed receiving a vendor nomination letter from its initial humanoid robotics customer, suggesting a potential ramp in humanoid-related bookings in the second half of 2026. Backlog appears supportive of continued activity, with the leadership forecasting that organic revenue growth in fiscal 2026 will exceed the 8%–10% band previously outlined in its three-year model.
Analysis: margins and growth optics beyond the headline numbers
From a margins perspective, the print looks like a step back from a year ago. The GAAP figures show a quarterly loss per share, while the adjusted metrics show modest improvement relative to the GAAP baseline but remain well below the prior-year levels. In other words, revenue is growing, but the cost structure or mix isn’t keeping pace yet, and the market is being asked to look through to a potential margin recovery as the new growth engines mature.
The revenue acceleration is real enough to grab attention—revenue forecast” and “EPS consensus” will be key watchwords for investors in the coming weeks—but the absence of a stated consensus in the release means investors are left to infer whether current results meet, miss, or exceed external expectations. The reported earnings surprise (or lack thereof) will hinge on whether market participants view the margin compression as a temporary phase tied to product mix, supply chain costs, or the ramp of higher-value, long-cycle programs such as humanoid robotics.
And then there’s the signaling from backlog and bookings. A book-to-bill ratio above 1, plus a humanoid robotics narrative, might be a bridge to stronger operating leverage if the demand mix shifts toward higher-margin products. Still, the current quarter’s margin trajectory cautions against extrapolating immediate profitability from top-line momentum.
Outlook and implications for peers
Management’s statement that fiscal 2026 organic revenue growth should exceed the previously outlined 8%–10% target frames a constructive longer-term trajectory, assuming the humanoid robotics pipeline materializes and the broader AI/data-center demand continues. For sector peers, the takeaway is nuanced: bookings strength and backlog signal durable demand, but margin discipline remains the watchword, particularly if input costs or product mix shifts persist through the second half of the year.
From a stock-valuation angle, investors will be weighing the growth cadence against the margin normalization path. If the humanoid initiative advances, and if the company can translate backlog into sustained revenue at a healthier margin, the EPS line—especially the GAAP-to-adjusted spread—could swing more decisively to the upside. In the meantime, the EPS and revenue forecast narratives will drive near-term positioning for VPG and its peers in precision sensing, specialty resistors, and related markets.
Note on the filing
The press release closes with a line indicating that “The Company noted that its second-quarter revenue was impacted by,” but the excerpt ends there. That incomplete line leaves open questions about the external factors weighing on the quarter, such as supply chain dynamics, product mix, or transient costs. Investors should await further detail or a subsequent earnings call for a fuller explanation and any management-guided bridge to the back-half trajectory.
Key takeaways
- VPG posted solid top-line growth in Q2’26, with net revenues of $83.9 million and an 11.7% year-over-year increase.
- Margins moved lower across the board—GAAP and adjusted—creating a near-term hurdle for earnings per share (EPS) to meaningfully impress, despite growth.
- Bookings surpassed $95 million, and the book-to-bill ratio of 1.14 points to a backlog-rich environment that could support a revenue ramp in the back half of the year.
- The humanoid robotics narrative adds a speculative growth dimension; a vendor nomination letter hints at potential longer-cycle, higher-margin opportunities if execution aligns with plans.
- Management’s forecast of fiscal 2026 organic revenue growth above the prior 8%–10% range is the critical signal; the market will scrutinize whether margins can recover as these growth engines scale.
- For investors tracking EPS, the lack of a disclosed EPS consensus in the release means watchers will rely on upcoming calls and peer commentary to gauge the earnings surprise potential.
Bottom line: the quarter is a reminder that momentum and profitability can diverge. The market may reward the company for a robust order book and a tentatively favorable growth outlook if it can bend the margin curve without sacrificing the top-line velocity.